Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.

By C. Whitney, M. Farley, J. Hadler, L. Harrison, N. Bennett, R. Lynfield, A. Reingold, P. Cieslak, T. Pilishvili, Delois M. Jackson and 3 more. New England Journal of Medicine, 2003

1,473 citations recorded by the source corpus.

Subfields: Epidemiology, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/fd5ca48ac8f3fdb9cca541c5e4fdb05d76eddb72

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. A. Torres
2. T. Welte
3. D. Ferreira
4. J. Weiser
5. D. Nathwani
6. J. Paton

Citations in the corpus

• Streptococcus pneumoniae: transmission, colonization and invasion (2018, background): “pneumoniae is one of many pathogens that bind to Nacetylglucosamine-β-(1,4)-galactose50,51.”
• Clinical features and prognostic factors in adults with bacterial meningitis. (2004, neutral): “Quadriparesis 6/550 (1) 4/243 (2) 2/237 (1)”
• Clinical and economic burden of community-acquired pneumonia among adults in Europe (2010, background): “Children are a reservoir for antibiotic-resistant pneumococci and are the most vulnerable to pneumococcal infections.(116) Vaccinating this age group with PCV may be an effective tool for preventing infections caused by drug-resistant strains.”